Abstract
There have been many studies linking the microbiome to a disease, including cancer. The microbiome is all the genetic material in the form of bacteria, fungi or viruses that exist in parts of the human body. The microbiome is reported to trigger cancer due to the presence of certain pathogenic microbes or the presence of dysbiosis. Therefore, it is necessary to analyse the diversity of the microbiome to see the relationship. Metagenomics is the latest technology that can be used to analyse the diversity of the microbiome in cancer. There are two approaches in metagenomic analysis, namely targeted sequencing and sequencing of the entire metagenome. This paper will discuss a targeted sequencing metagenomic approach for the identification of microbial diversity in cancer.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
